LivingGLP1
Study S000887

Perioperative Stress Hyperglycemia in General and Vascular Surgery Patients

Registration

Registration
NCT04862234
Study type
INTERVENTIONAL
Allocation
RANDOMIZED
Phase
PHASE4
Masking
DOUBLE
Status
TERMINATED
Enrollment
16
Start
2021-08-06
Primary completion
2023-06-22
Lead sponsor
Emory University
Conditions
Hyperglycemia Stress
Interventions
DRUG:Dulaglutide; DRUG:Placebo; DEVICE:Continuous glucose monitor (CGM), blinded
Results posted
TRUE
Individual participant data sharing
YES
Secondary identifiers
NIH:K23DK122199

Registered primary outcomes

  • Percentage of Time in Target Glucose Range (70-140 mg/dL) by CGM [During hospitalization (up to 5 days postoperatively)]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.